Dimethylamine

Dimethylamine

SCHEMBL9504815

CC(Oc1ccccc1)Oc1ccccc1.CNC

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.46
SLC6A4 P31645 1/20 0.46
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44
CA4 P22748 1/20 0.42
MAOA P21397 2/20 0.41
PTGS1 P23219 1/20 0.41
LMNA P02545 2/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
HTR1B P28222 2/20 0.40
HTR1D P28221 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
PKM P14618 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL542873 0.92 KDM4E (0.50) KDM4ESLC6A4MTNR1AMTNR1BCA4
Methylamine SCHEMBL10763289 0.87 KDM4E (0.47) KDM4ESLC6A4MTNR1AMTNR1BCA4
SCHEMBL9770385 0.85 KDM4E (0.46) KDM4ESLC6A4MTNR1AMTNR1BCA4
SCHEMBL9617076 0.83 KDM4E (0.44) KDM4ESLC6A4MTNR1AMTNR1BCA4
Bicarbonate SCHEMBL3270191 0.83 GAA (0.52) KDM4EMTNR1AMTNR1BPTGS1LMNA
SCHEMBL12960634 0.83 KMT2A (0.52) KDM4ECA4LMNAGAAMEN1
SCHEMBL9296320 0.82 KDM4E (0.47) KDM4ESLC6A4MTNR1AMTNR1BCA4
SCHEMBL29159322 0.82 KDM4E (0.47) KDM4ESLC6A4MTNR1AMTNR1BCA4
SCHEMBL2356964 0.82 CA4 (0.50) KDM4ESLC6A4MTNR1AMTNR1BCA4
SCHEMBL10749798 0.81 CA4 (0.64) KDM4ECA4ALDH1A1LTA4HTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0238765-B1 2,2-DIPHENOXY-N,N-DIMETHYLAMINOETHANE FOR IMPROVING CEREBRAL OXYGENATION LIPHA - Lyonnaise Industrielle Pharmaceutique (FR) 1993-07-21 EP claimed
EP-0238765-A2 2,2-Diphenoxy-N,N-dimethylaminoethane for improving cerebral oxygenation LIPHA - Lyonnaise Industrielle Pharmaceutique (FR) 1987-09-30 EP claimed
EP-0238765-B1 2,2-DIPHENOXY-N,N-DIMETHYLAMINOETHANE FOR IMPROVING CEREBRAL OXYGENATION LIPHA - Lyonnaise Industrielle Pharmaceutique (FR) 1993-07-21 EP disclosed
EP-0238765-B1 2,2-DIPHENOXY-N,N-DIMETHYLAMINOETHANE FOR IMPROVING CEREBRAL OXYGENATION LIPHA - Lyonnaise Industrielle Pharmaceutique (FR) 1993-07-21 EP disclosed
US-4762855-A Novel pharmaceutical compositions improving oxygenation of the brain and a process for their production ALBERT ROLLAND S.A. (FR) 1988-08-09 US disclosed
EP-0238765-A2 2,2-Diphenoxy-N,N-dimethylaminoethane for improving cerebral oxygenation LIPHA - Lyonnaise Industrielle Pharmaceutique (FR) 1987-09-30 EP disclosed
EP-0238765-A2 2,2-Diphenoxy-N,N-dimethylaminoethane for improving cerebral oxygenation LIPHA - Lyonnaise Industrielle Pharmaceutique (FR) 1987-09-30 EP disclosed
EP-0238765-A2 2,2-Diphenoxy-N,N-dimethylaminoethane for improving cerebral oxygenation LIPHA - Lyonnaise Industrielle Pharmaceutique (FR) 1987-09-30 EP disclosed